Cloud native EDA tools & pre-optimized hardware platforms
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Highlights: Broad IP portfolio for IoT designs includes logic libraries, memory compilers, non-volatile memory, data converters, wired and wireless interface IP, security IP, processor cores and a...
Highlights: Synopsys' successful tape-out of IP for TSMC 10-nm process includes USB 3.1, USB 3.0, USB 2.0, HSIC, PCI Express 3.0, PCI Express 2.0 and MIPI D-PHY Tape-out of DesignWare IP enables...
Highlights: IC Compiler II certified for TSMC's 10-nm FinFET V0.9 process Certification includes a new reference flow for the full suite of digital, signoff and custom implementation tools from...
Synopsys, Inc. (Nasdaq:SNPS) today announced that TSMC has certified its IC Compiler™ II place and route product for V0.9 of 10-nanometer (nm) FinFET process technology (N10FF), and are on track...
Highlights: HAPS-80 FPGA-based prototyping system with ProtoCompiler software delivers up to 100 MHz multi-FPGA performance and new automated high-speed pin-multiplexing ProtoCompiler software,...
Synopsys, Inc. (Nasdaq: SNPS), today announced it will host a webcast for investors on Thursday, Sept. 17, 2015. Aart de Geus, Synopsys chairman and co-CEO, Andreas Kuehlmann, senior vice...
Highlights: Latest cores extend the ARC EM DSP Processor Family, combining high efficiency control and signal processing for ultra-low power, always-on applications New XY memory support in EM9D...
Highlights: Design Compiler Graphical deployed for implementation of Renesas designs. Significant reduction in routing congestion leads to faster timing and smaller area. Congestion optimization...
Synopsys, Inc. (Nasdaq: SNPS), will host a free one-day event focused on the latest technologies and trends in embedded processor IP, software and programming tools. In this dual-track event,...
Synopsys, Inc. (Nasdaq:SNPS) today announced that its Board of Directors has replenished its existing stock repurchase authorization back to $500 million. "Synopsys is committed to our long-term...